Company / R&D per Share
ENDRA Life Sciences Inc. R&D per Share History
FY2017-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.70
FY2020
5-year range
$0.49 / $2.67
FY2017-FY2020
Trend
+10.5%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.49 to $0.70 over the past 2 years.
Based on SEC 10-K filings.
0.70 in FY2020 with a 3-year CAGR of -35.9%.
Improved from $0.49 to $0.70 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -35.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, r&d per share increased 10.5% year-over-year.
Company context
Key Data Points
- Altman Z-Score -7.14 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | $0.70 | +10.5% |
| FY2019 | $0.64 | +29.3% |
| FY2018 | $0.49 | -81.6% |
| FY2017 | $2.67 | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026